tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Neurocrine (NBIX) and Medtronic (MDT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Danaher (DHRResearch Report), Neurocrine (NBIXResearch Report) and Medtronic (MDTResearch Report).

Danaher (DHR)

Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Danaher today and set a price target of $258.00. The company’s shares closed last Tuesday at $252.31.

According to TipRanks.com, Ryskin is a 3-star analyst with an average return of 3.0% and a 51.5% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, Phibro Animal Health, and Elanco Animal Health.

Currently, the analyst consensus on Danaher is a Strong Buy with an average price target of $271.43, implying a 15.0% upside from current levels. In a report issued on April 10, Barclays also maintained a Hold rating on the stock with a $260.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Neurocrine (NBIX)

In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Neurocrine, with a price target of $140.00. The company’s shares closed last Tuesday at $141.06, close to its 52-week high of $148.37.

According to TipRanks.com, Bansal is a 4-star analyst with an average return of 6.4% and a 54.4% success rate. Bansal covers the Healthcare sector, focusing on stocks such as Cerevel Therapeutics Holdings, Mineralys Therapeutics, Inc., and BioMarin Pharmaceutical.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Neurocrine with a $152.14 average price target, which is a 13.8% upside from current levels. In a report released today, Needham also maintained a Hold rating on the stock.

Medtronic (MDT)

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic, with a price target of $102.00. The company’s shares closed last Tuesday at $80.97.

According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 10.0% and a 56.8% success rate. Biegelsen covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, GE Healthcare Technologies Inc, and Bausch + Lomb Corporation.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medtronic with a $93.87 average price target, implying a 16.5% upside from current levels. In a report issued on April 8, TD Cowen also maintained a Buy rating on the stock with a $95.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on DHR:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles